Investing
Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)
Published:
Last Updated:
These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls:
Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup.
Aeropostale (NYSE: ARO) Raised to Neutral at Piper Jaffray.
Biogen Idec (NASDAQ: BIIB) Started as Neutral at Piper Jaffray.
Celgene (NASDAQ: CELG) Started as Overweight at Piper Jaffray.
China Advanced Construction Materials (NASDAQ: CADC) Started as Buy at Roth Capital.
Facet Biotech (NASDAQ: FACT) Cut to Market Perform at BMO Capital.
HSBC (NYSE: HBC) Cut to Neutral at Goldman Sachs.
Luminex (NASDAQ: LMNX) Started as Buy at Jefferies.
New Oriental Education (NYSE: EDU) Started as Buy at Deutsche Bank.
Pacific Sunwear of California (NASDAQ: PSUN) Cut to Market Perform at FBR.
Silicon Graphics International (NYSE: SGI) Started as Market Perform at Morgan Keegan.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
